The Mutation Matters: <scp>CSF</scp> Profiles of <scp>GCase</scp>, Sphingolipids, α‐Synuclein in <scp>PD<sub>GBA</sub></scp>

Stefanie Lerche(German Center for Neurodegenerative Diseases), Kathrin Brockmann(Oregon Health & Science University), Milan Zimmermann(German Center for Neurodegenerative Diseases), S. Pablo Sardi(Sanofi (France)), Samantha J. Hutten(Michael J. Fox Foundation), Judith Böhringer(University Children's Hospital Tübingen), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Xuan-Mai Petterson(Mayo Clinic), Ruby W. Chiang(AVEO Oncology (United States)), Thomas Gasser(Hertie Institute for Clinical Brain Research), Gerrit Machetanz(German Center for Neurodegenerative Diseases), Ingeborg Krägeloh‐Mann(University Children's Hospital Tübingen), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), Claudia Schulte(School of the Art Institute of Chicago), Ingolf Lachmann, Douglas Galasko(University of Minnesota), Hye Jung Park(AVEO Oncology (United States)), Benjamin Röeben(German Center for Neurodegenerative Diseases), Ann‐Kathrin Hauser(German Center for Neurodegenerative Diseases), Christian Deuschle(German Center for Neurodegenerative Diseases), Isabel Wurster(German Center for Neurodegenerative Diseases), Brit Mollenhauer(Paracelsus Elena Klinik Kassel), Katharina Waniek(Leipzig University), Michelle M. Mielke(Mayo Clinic), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Bing Wang(Northeastern University), Clemens R. Scherzer(Brigham and Women's Hospital)

Movement Disorders

February 6, 2021

Cited by 76

Related Papers

|Movement Disorders|2015|7.4k

|Neurology|2017|4.4k

|Movement Disorders|2017|2.3k

|New England Journal of Medicine|2009|2.1k

|Nature Genetics|2009|2k